key: cord-0718883-cv7tb3u1 authors: Malhis, Joseph R.; Mahmoud, Aysam; Belote, Alex; Ebers, Andrew title: Case of ehrlichiosis induced Guillain-Barre Syndrome in a 71 year-old female date: 2021-10-05 journal: IDCases DOI: 10.1016/j.idcr.2021.e01301 sha: ede4b384d06648bfea7cabe303f86c3a82b60eee doc_id: 718883 cord_uid: cv7tb3u1 Guillain-Barre Syndrome (GBS) is a rare autoimmune demyelinating polyradiculoneuropathy that causes an ascending paralysis and flaccid weakness. Tick paralysis is a mimic of GBS as symptoms include generalized weakness and paralysis. However, symptom onset and timing as well as lab findings can distinguish between them. We present a case of a 71-year-old female who complained of generalized weakness and dizziness starting three weeks prior to admission. During that time, she had fevers and chills and a questionable insect bite. Her lab values indicated thrombocytopenia and elevated liver enzymes. PCR titers were positive for ehrlichiosis and she was started on doxycycline then discharged. She returned over a week later with worsening symptoms despite treatment. There was concern she may had Heartland or Bourbon virus but titers were negative. Her neurological exam showed numbness and areflexia in her lower extremities which progressed since her first encounter. She was given IVIG and her symptoms improved and recovered slowly. Although ehrlichiosis is not a common cause for GBS, the pathogenesis is like Lyme disease or Campylobacter jejuni. This patient had clinical symptoms that were like tick-borne illness yet as her disease progressed, it illustrated the need for an expanded differential diagnosis. There is very little literature about ehrlichia inducing GBS. It is important to keep a broad differential as sometimes common syndromes do not always come from common pathogens and with the COVID-19 pandemic having similar results, we are learning new things that may potentially be new standards in medical education. Guillain-Barre Syndrome (GBS) is an acute autoimmune demyelinating polyradiculoneuropathy that induces rapid and progressive flaccid weakness. It can be life-threatening due to the prospects of developing respiratory insufficiency as seen in 25% of cases [1] . After an acute gastrointestinal or respiratory infection, a T-cell mediated immune response creates antibodies which attack peripheral nerves and myelin sheaths [2] . Unlike botulism which is a descending paralysis, this is an ascending paralysis, affecting the lower extremities first then up to the bulbar and respiratory function. As it ascends, it may reach the diaphragm, and it is essential to assess respiratory status in patients as they may require intubation due to the respiratory insufficiency. Areflexia may also occur, initiating in the lower extremities [2] . Diagnosis can be made clinically as described but confirmation can be done via lumbar puncture and electromyography. Lumbar puncture may find mildly elevated leukocyte count but very elevated protein count in the CSF. The increased protein is due to albuminocytologic dissociation [2] . The increased protein can cause papilledema in patients, affecting the patient's vision. Variants of GBS like Miller-Fisher syndrome which leads to descending weakness with oculomotor palsy, ataxia, cranial neuropathies occurs due to antibodies attacking the GQ1b ganglioside protein [2] . Similar to Miller-Fisher syndrome, there are other antibodies that attack peripheral nerves like anti-GM1, anti-GD1A, anti-GT1A, and anti-GQ1B. Sensitivity is 60% with anti-GM1 antibodies in acute motor axonal neuropathy and up to more than 90% with anti-GQ1B antibodies in Miller Fisher syndrome [3] . Other known causes for inducing GBS are respiratory or gastrointestinal infections. In Campylobacter jejuni, lipooligosaccharide in the outer membrane of the bacteria is similar to gangliosides that are part of the peripheral nerves. Hence this causes a cross-reaction, leading to attack on the host's peripheral nerves [3] . There was also a high incidence of GBS with both the Zika outbreak as well as the 1976 influenza A/H1N1 vaccinations. Since then, the cases have diminished with subsequent vaccinations over the years. There may be one in one million cases of developing GBS from the flu vaccine [3] . Treatment for GBS includes intravenous immunoglobulin (IVIG) therapy or plasma exchange [1] . IVIG provides immunomodulating action and can be given at a dose of 2 gm/kg over 5 days. Plasma exchange removes any of the pathogenic modulators that triggered the GBS. Both forms of therapy have been equally efficacious but the use of steroids does not provide any benefit compared to placebo [3] . If done early, 85% of patients recover independent ambulation [3] . A healthy, active 71-year-old female with no significant past medical history presented with dizziness and generalized weakness. She moved from California to Northwest Arkansas two months prior and she denied having any visitors since the move. She was active and walked for 2 miles daily with her husband regularly prior to this admission. For three weeks, she had significant dizziness and felt like the room was spinning, having difficulty ambulating. She also noticed visual changes and complained of chills for two weeks intermittently and fever prior to admission of 102F. She felt "heavy" and could not hold her neck up and complained of pain along her neck when her chin touched her chest. She also complained of intermittent abdominal pain. She was tested for COVID-19 and her PCR was negative. CT head and MRI brain were negative for any acute processes. MRI cervical spine found mild stenosis in C6 and C7. She did have a notable insect bite on her left arm but she denied knowing if it was a tick bite. Labs were notable for thrombocytopenia with platelets at 105k (150-450k) and elevated liver enzymes with AST 125 (40) and ALT 95 (40) but as high as 260 and 204, respectively after 3 days. Lumbar puncture found low count of 1 WBC, it being lymphocytic dominant and protein of 37.7. She was hypoxic but had good oxygen saturation on 2 L of supplemental oxygen and she denied respiratory symptoms. To assess for tick-borne related illness, a tick-borne panel was done checking titers and PCR for Rocky Mountain Spotted Fever (RMSF) IgG and IgM, ehrlichia caffeenisis and ewingii, babesia microti and duncani anaplasma phagocytophilum, Lyme antibody and IgG in CNS as well as HSV-1 and − 2 PCR, influenza A and B via PCR, mononucleosis, West Nile Virus PCR, cryptococcal antigen in CSF and campylobacter antigen. Final result was positive for Ehrlichia chaffeensis. She was started on doxycycline and after she clinically improved, she was discharged home on hospital day 4. She completed a 12-day course of doxycycline, however she returned to the ED 8 days after discharge with complaints of generalized weakness and tingling sensation. Repeat COVID-19 PCR was ordered and it was again negative, 10 days after her first assessment. She was hyponatremic with a sodium of 125 and complained of diarrhea. Initial differential for her symptoms was thought to be related to her hyponatremia for which she was given normal saline and responded well to it. She had an unsteady gait and required a walker to ambulate. She stated her numbness on her right side improved after finishing the doxycycline, but she continued to have tingling in her feet. During this admission, she also had difficulty urinating and required straight foley catheterization. Neurology and Infectious Disease were consulted. Infectious disease pursued studies to assess for concomitant Heartland or Bourbon Virus given her failure to fully recover after a course of doxycycline. Neurology was concerned about an acute inflammatory demyelinating polyneuropathy like Guillain-Barre Syndrome with her new onset worsening neurological complaints. Repeat MRI of the cervical, thoracic and lumbar spine found no new changes. Repeat lumbar puncture found low WBC and glucose but elevated protein at 57.7. On physical exam, she had decreased vibration in her extremities with a glove and stocking pattern and deep tendon reflexes were not elicited on lower extremities. Repeat lumbar puncture found elevated protein but was otherwise unremarkable. She was then started on IVIG therapy with clinical improvement. Heartland and Bourbon virus titer results were negative. She was discharged to rehab and improved significantly. This patient's presentation initially was thought to be a tickborne illness given her thrombocytopenia, elevated liver enzymes and recent insect bite. Thus, she was treated with doxycycline. Despite some initial improvement, her condition progressed with worsening neurologic symptoms despite antibiotic therapy, raising the possibility of Heartland or Bourbon Virus. There is overlap with tick-paralysis and GBS. At first, her symptoms initially seemed like tick-paralysis. However, the time course was more insidious taking weeks rather than hours or days. Her albuminocytologic dissociation is associated with inflammation of the nerve root. Protein counts will often be greater than 55 as it was in her case. She responded very well with IVIG therapy. There have been reported cases of tick-borne illness that have not recovered despite tetracycline treatment. There was a case in 2014 in Eastern Kansas for which a 50 year old male who was found to have several tick bites had complaints of nausea, vomiting and diarrhea, followed by fever, myalgias, headaches and arthralgias the next day. He was started on doxycycline on day 3 but his condition worsened. Despite having the classic symptoms as described for tick-borne illness including maculopapular rash and lymphadenopathy, he was unresponsive to doxycycline and his serum titers were negative for Rocky Mountain Spotted Fever, Lyme Disease and Ehrlichiosis, tularemia, babesiosis, Q fever, Aspergillus, Histoplasma, Hep B and C, West Nile Virus and HIV [4] . This patient was the first case of Bourbon Virus, named in part from the location of Bourbon County, Kansas. Since then, an extensive study was done to surveille the region of Bourbon County and neighboring Linn County in 2015. Based on the collection of 20,639 host-seeking ticks representing four species from 12 sites: Amblyomma americanum (L.) (Acari: Ixodidae) and Dermacentor variabilis (Say) (Acari: Ixodidae), three tick pools, all composed of adult A. americanum ticks collected in Bourbon County, were virus positive. Two pools were Heartland virus (Family Bunyaviridae: Genus Phlebovirus) positive, and one was Bourbon virus positive [5] . These two new viruses affect the state region including Kansas, Missouri, Oklahoma and Arkansas. In our case, Northwest Arkansas is a region in which tick-borne illnesses are prevalent, Bourbon and Heartland Virus are also unique to the region. Common causes of GBS as listed previously are Lyme disease or Campylobacter jejuni infection but the mechanism of action between these infections and ehrlichiosis is not different. The body will elicit an immune response which causes a cross-reaction thus attacking the peripheral nervous system. In addition, Lyme disease is a regional infection, predominantly seen in the Northeastern United States. Many patients in the Arkansas, Missouri, Kansas region are worked up for Lyme Disease if they have a suspicion for tick-borne disease but it is not as common compared to Ehrlichia or Rocky Mountain Spotted Fever. There are disorders that may mimic GBS like tick-paralysis, HIV, and West Nile Virus which have similar clinical manifestations. Tick paralysis is induced by neurotoxin in the tick's salivary glands. Symptoms include ascending paralysis which would occur over hours to days. Deep tendon reflexes would be diminished or absent and if the tick is not removed, the paralysis would continue and it will affect the cranial nerves [6] . GBS and tick-paralysis rarely presents with fever or pain. Both may affect the cranial nerves but GBS affects III, IV, VI, VII [6] . To distinguish them apart, pupillary dilation is seen with tick paralysis and the CSF would show pleocytosis in West Nile Virus or HIV rather than albuminocytologic dissociation [3] . With GBS, the onset of ascending paralysis is slower compared to tick-paralysis. Although ehrlichiosis is not pathognomonic for Guillain-Barre, it is important to not rule out as a cause. With the COVID-19 outbreak, there have been reported cases of GBS induced by COVID. It too can cause an immune response to the nervous system. It is essential as in any other case that a proper history and physical is performed to elucidate the underlying cause. With her being new to Northwest Arkansas and her hiking history, it makes sense that she developed ehrlichia and less likely lyme disease. Her timeline of systems and lab findings did correlate with ehrlichia but also Guillain-barre, especially the CSF findings. So although it does not follow the classic "textbook" criteria, looking at the case as a whole makes the diagnosis. As clinicians across the nation deal with the current pandemic of the novel COVID-19 virus and learning the variable symptoms, there may be more cases of COVID-19 induced GBS or other AIDP disorders and may eventually be part of our regular textbook learning in the future. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis Inflammatory Polyradiculoapathies: Guillain-barre Syndrome Guillain Barre Syndrome Treasure Island (FL): StatPearls Publishing Novel thogotovirus associated with febrile illness and death Surveillance for Tick-Borne Viruses Near the Location of a Fatal Human Case of Bourbon Virus (Family Orthomyxoviridae: Genus Thogotovirus) in Eastern Kansas Borne Illnesses (Lyme, Ehrlichiosis, Babesiosis and Tick Paralysis) The authors declare there is no conflict of interests regarding the publication of this paper.